News

Article

Toric IOLs effectively correct some types of irregular astigmatism

Author(s):

The angled bow-tie pattern of astigmatism was corrected more accurately compared with the asymmetric bow-tie pattern of astigmatism

(Image Credit: AdobeStock/Oktay)

(Image Credit: AdobeStock/Oktay)

Implantation of toric intraocular lenses (IOLs) effectively corrects specific types of irregular corneal astigmatism in patients undergoing cataract surgery. The angled bow-tie pattern of astigmatism was corrected more accurately compared with the asymmetric bow-tie pattern of astigmatism,1 according to first author Xiteng Chen, MD. She is from the Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.

Chen and associates emphasized the importance of eliminating as much residual astigmatism as possible after cataract surgery to obtain the best visual acuity (VA) without glare, monocular diplopia, and visual distortion. Toric IOLs have been widely adopted as an effective and dependable solution for patients with regular corneal astigmatism.2,3 However, the corrective effect of toric IOLs for irregular corneal astigmatism needs to be determined.

The investigators conducted a retrospective cohort study to observe the corrections obtained following the implantation of toric IOLs for specific types of irregular corneal astigmatism. The study included 34 with either the asymmetric bow-tie pattern of astigmatism (type I) or the angled bow-tie pattern (type II). The investigators compared the changes in the preoperative corneal astigmatism, VA, manifest refraction, and objective visual quality between the 2 groups.

Chen and colleagues reported that the average uncorrected distance VA improved significantly from 0.86 ± 0.40 logarithm of the minimum angle of resolution (logMAR) to 0.22 ± 0.15 logMAR and the preoperative corneal astigmatism of 2.05 ± 0.90 diopters (D) improved to 0.78 ± 0.57 D (P < 0.001 for both comparisons), with 32% of eyes within 0.50 D.

A comparison of the 2 groups showed that the residual astigmatism prediction errors of the type I and type II cases were 0.97 ± 0.68 D and 0.66 ± 0.37 D, respectively (P = 0.100). The mean spherical equivalent prediction error in the type II cases was significantly smaller than that in type I cases (0.07 ± 0.36 D and − 0.29 ± 0.52 D, respectively) (P = 0.030).

The authors concluded, “The toric IOL effectively corrected specific types of irregular corneal astigmatism in cataract surgery. The eyes with the angled bow-tie pattern showed higher accuracy in refractive predictions compared to the eyes with the asymmetric bow-tie pattern.

References:
  1. Chen X, Jiang Y, Gao N, et al. Effectiveness of toric intraocular lens implantation for correcting irregular corneal astigmatism in cataract eyes. Sci Rep. 2024;14: 8868; https://doi.org/10.1038/s41598-024-59303-0
  2. Mencucci R, Giordano C, Favuzza F, et al.Astigmatism correction with toric intraocular lenses: Wavefront aberrometry and quality of life. Br J Ophthalmol. 2023;97:578–582; https://doi.org/10.1136/bjophthalmol-2013-303094
  3. Thomas BC, Khoramnia R, Auffarth GU, Holzer MP. Clinical outcomes after implantation of a toric intraocular lens with a transitional conic toric surface. Br J Ophthalmol. 2018;102:313–316; https://doi.org/10.1136/bjophthalmol-2017-310386

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.